Frontlight ResearchEarly access
Trial site
Hengshui People's Hospital
- 5running trials
- 4closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Stroke5 trials
- Colorectal cancer1 trial
- Coronary artery disease1 trial
- Gastric and oesophageal cancer1 trial
- Uterine fibroids1 trial
- Phase
- Phase 23 trials
- Phase 33 trials
- Status
- Completed4 trials
- Recruiting3 trials
- Not yet recruiting2 trials
- Lead sponsor
- Beijing Tiantan Hospital2 trials
- Qun Zhao2 trials
- Kunming Pharmaceuticals, Inc.1 trial
- Lepu Medical Technology (Beijing) Co., Ltd.1 trial
- Peking Union Medical College Hospital1 trial
- and 2 more
Running trials
Not yet recruiting
Ongericimab Injection Reducing Recurrence of Ischemic Stroke
Recruiting
Multimodal AI for Predicting Response to Neoadjuvant Immunotherapy in Gastric Cancer (PRISM-GC)
Recruiting
Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke
Recruiting
Not yet recruiting
Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Stroke2 recruiting
- Colorectal cancer1 recruiting
- Coronary artery disease1 recruiting
- Gastric and oesophageal cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 15 Nov 2026